News

Natco Pharma aims to launch generic of Roche’s rare disease drug after favourable ruling in patent infringement case
The company said it has decided to price its version of Risdiplam product at Rs 15,900, and further added that it intends to ...
Natco Pharma shares legal update on Risdiplam patent; stock up 3%
The stock rose 2.95 per cent to hit a high of Rs 789. It was last seen trading 1.44 per cent up at Rs 777.45. At this price, ...
Natco Pharma to price Risdiplam at ₹15,900
Natco Pharma updates on Risdiplam launch in India, Delhi High Court denies Roche's injunction plea, pricing set at ₹15,900.
Medical Dialogues6d
Natco Pharma Executive VP - Technology Transfer, Intellectual Property Rights & Regulatory Affairs (API), Dr Ramesh Dandala, superannuates
Telangana: Natco Pharma has announced the superannuation of Dr Ramesh Dandala, Executive Vice President - Technology Transfer ...
Medical Dialogues9d
Natco Pharma Tummala Venkata Rao supperannuates as Vice President - Production
Natco Pharma has announced the supperannuation of Tummala Venkata Rao, Vice President - Production of the Company."With ...
CNBCTV187d
Trump Reciprocal Tariffs: These Pharma stocks now have the highest upside potential
Other names on the Nifty Pharma index that has a significant upside potential include Aurobindo Pharma and Ajanta Pharma, both of which have an upside potential of 23%.
The Financial Express7d
Trump tariff impact: Pharma stocks surge over 4% on tariff exemption
It’s a party for pharma stocks on Dalal Street. The Nifty Pharma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA ...
Natco to price Risdiplam generic at ₹15,900
Natco Pharma plans to launch generic Risdiplam pending Delhi High Court decision, offering discounts to patients.